Skip to main content
SpringerLink
Log in

CASE REPORT: Anaphylaxis-Like Reaction to Infliximab in a Patient with Crohn's Disease

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Hanauer SB: Safety of infliximab in clinical trials. Aliment Pharmacol Ther 13:16S–22S, 1999

    Google Scholar 

  2. Sandborn WJ, Hanauer SB: Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflamm Bowel Dis 5:119–133, 1999

    PubMed  Google Scholar 

  3. Soykan I, Ertan C, Ozden I: Severe anaphylactic reaction in infliximab: Report of a case: Am J Gastroenterol 2395–2396, 2000 (letter)

  4. Puchner T, Kugathasan S, Kelly K, Binion D: Successful desensitization and therapeutic use of infliximab in adult and pediatric Crohn's disease patients with prior anaphylactic reaction. Inflamm Bowel Dis 7:34–37, Feb 2001

    PubMed  Google Scholar 

  5. Wintroub BU, Stern RS: Cutaneous drug reactions. In AS Fauci, E Braunwald, KJ Isselbacher, et al (eds). Harrison's Principles of Internal Medicine. New York, McGraw-Hill 304–310, 1998

    Google Scholar 

  6. Adkins JC, Spencer C: Edrecolomab (monoclonal antibody 17-1A) Drugs 56:619–626, 1998

    PubMed  Google Scholar 

  7. Onrust SV, Lamb HM, Balfour JA: Rituximab. Drugs 58:79–88, 1999

    PubMed  Google Scholar 

  8. Welt S, Ritter G: Antibodies in the therapy of colon cancer. Semin Oncol 26:683–690, 1999

    PubMed  Google Scholar 

  9. Kam LY, Vasiliauskas EA, Abreu MT, et al: Attenuation of response to multiple retreatment infliximab infusions for active Crohn's disease: Potential factors that minimize decreased response. Gastroenterology 118:A655, 2000 (abstract)

    Google Scholar 

  10. Rutgeerts P, D'Haen's G, Targan S, et al: Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. Gastroenterology 117:761–769, 1999

    PubMed  Google Scholar 

  11. Kavanaugh AF: Anti-tumor necrosis factor—a monoclonal antibody therapy for rheumatoid arthritis. Rheum Dis Clin Am 24:593–612, 1998

    Google Scholar 

  12. Baert FJ, Rutgeerts PR: Anti-TNF strategies in Crohn's disease: Mechanisms, clinical effects, indications. Int J Colorect Dis 14:47–51, 1999

    Google Scholar 

  13. Multani PS, Grossbard: Monoclonal antibody-based therapies for hematologic malignancies. J Clin Oncol 16:3691–3710, 1998

    PubMed  Google Scholar 

  14. Wallis WJ, Furst DE, Strand V, et al: Biologic agents and immunotherapy in rheumatoid arthritis: progress and prospective. Rheum Dis Clin North Am 24:537–563, 1998

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Texas-Houston Medical School, Houston, Texas, USA

    Maeve O'Connor

  2. Division of Gastroenterology and Hepatology, Northwestern University Medical School, Chicago, Illinois

    Alan Buchman

  3. Division of Allergy and Immunology, University of Texas-Houston Medical School, Houston, Texas, USA

    Gailen Marshall

Authors
  1. Maeve O'Connor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alan Buchman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gailen Marshall
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

O'Connor, M., Buchman, A. & Marshall, G. CASE REPORT: Anaphylaxis-Like Reaction to Infliximab in a Patient with Crohn's Disease. Dig Dis Sci 47, 1323–1325 (2002). https://doi.org/10.1023/A:1015326715456

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015326715456

Keywords

Search

Navigation